News ITA

Genenta to take part in gene therapy panel and two virtual investor events in January 2021

Posted on January 26, 2021 by genenta
News ENG, News ITA

Temferon TM, an ex-vivo genetically modified cell therapy aiming to fill the gaps for solid tumor immunotherapy

Posted on November 30, 2020November 30, 2020 by genenta
News ENG, News ITA

MedNous: Stephen Quinto to chair Genenta Science

Posted on November 25, 2020December 9, 2020 by genenta
News ENG, News ITA

EconomyUp: Con una rock start del biotech alla presidenza Genenta Science diventa più americana

Posted on November 25, 2020December 9, 2020 by genenta
News ENG, News ITA

Milano Finanza: Stephen Squinto nuovo presidente di Genenta

Posted on November 24, 2020December 9, 2020 by genenta
News ENG, News ITA

Be Beez: Genenta Science nomina presidente Stephen Squinto, rock star del biotech Usa

Posted on November 23, 2020December 9, 2020 by genenta
News ENG, News ITA

About Pharma: Terapie geniche, Stephen Squinto è il nuovo presidente di Genenta Science

Posted on November 23, 2020December 9, 2020 by genenta
News ENG, News ITA

Biotech: facciamo il punto con Pierluigi Paracchi

Posted on June 18, 2020 by genenta
News ENG, News ITA

Come viene prodotto un farmaco? Carlo Russo, MD, CMO&Head of Development, Genenta

Posted on May 5, 2020May 5, 2020 by genenta
News ENG, News ITA

MedNous, Letter From Milano – Assesing the coronavirus challege

Posted on April 20, 2020 by genenta
News ENG, News ITA
  • 1
  • 2
  • 3
  • …
  • 7
  • »

CONTACT

Via Olgettina 58
20132 Milano
Italy

    LaunchLabs - Alexandria Center
14th Floor
Suite 1456E
430 East 29th Street
New York NY 10016
United States

Email Inquiry

I read the information pursuant to art. 13 of EU Regulation no. 2016/679 concerning the protection of personal data
Please confirm that you have read the information on the processing of personal data
© 2015 genenta science. All Rights Reserved

Terms & Conditions - Cookie Policy